BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17510979)

  • 1. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
    Lovell MA; Markesbery WR
    J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
    Markesbery WR; Lovell MA
    Arch Neurol; 2007 Jul; 64(7):954-6. PubMed ID: 17620484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
    Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
    Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of increased oxidative damage in subjects with mild cognitive impairment.
    Keller JN; Schmitt FA; Scheff SW; Ding Q; Chen Q; Butterfield DA; Markesbery WR
    Neurology; 2005 Apr; 64(7):1152-6. PubMed ID: 15824339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.
    Wang J; Markesbery WR; Lovell MA
    J Neurochem; 2006 Feb; 96(3):825-32. PubMed ID: 16405502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease.
    Guidi I; Galimberti D; Lonati S; Novembrino C; Bamonti F; Tiriticco M; Fenoglio C; Venturelli E; Baron P; Bresolin N; Scarpini E
    Neurobiol Aging; 2006 Feb; 27(2):262-9. PubMed ID: 16399211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative inactivation of the proteasome in Alzheimer's disease.
    Cecarini V; Ding Q; Keller JN
    Free Radic Res; 2007 Jun; 41(6):673-80. PubMed ID: 17516240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment.
    Beal MF
    Neurobiol Aging; 2005 May; 26(5):585-6. PubMed ID: 15708432
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
    Singh M; Dang TN; Arseneault M; Ramassamy C
    J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoproteins and lipid peroxidation in Alzheimer's disease.
    Bassett CN; Montine TJ
    J Nutr Health Aging; 2003; 7(1):24-9. PubMed ID: 12679837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence linking genetics, environment, and epigenetics to impaired DNA repair in Alzheimer's disease.
    Coppedè F; Migliore L
    J Alzheimers Dis; 2010; 20(4):953-66. PubMed ID: 20182042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
    Wang J; Xiong S; Xie C; Markesbery WR; Lovell MA
    J Neurochem; 2005 May; 93(4):953-62. PubMed ID: 15857398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
    Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
    Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients.
    Migliore L; Fontana I; Trippi F; Colognato R; Coppedè F; Tognoni G; Nucciarone B; Siciliano G
    Neurobiol Aging; 2005 May; 26(5):567-73. PubMed ID: 15708428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress signalling in Alzheimer's disease.
    Zhu X; Raina AK; Lee HG; Casadesus G; Smith MA; Perry G
    Brain Res; 2004 Mar; 1000(1-2):32-9. PubMed ID: 15053949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
    Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.